Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance
Kimberly M Cirelli,
Diane G. Carnathan,
Oscar L. Rodriguez,
Jacob T. Martin,
Amit A Upadhyay,
Chiamaka A. Enemuo,
Etse H. Gebru,
Cristopher A. Cottrell,
Amber N. Wolabaugh,
Mariane B. Melo,
Daniel W Kulp,
Dennis R. Burton,
Steven E Bosinger,
William R Schief,
Andrew B. Ward,
Corey T. Watson,
Darrell J Irvine,
Posted 01 Oct 2018
bioRxiv DOI: 10.1101/432666 (published DOI: 10.1016/j.cell.2019.04.012)
Posted 01 Oct 2018
The observation that humans can produce broadly neutralizing antibodies (bnAbs) against HIV-1 has generated enthusiasm about the potential for a bnAb vaccine against HIV-1. Conventional immunization strategies will likely be insufficient for the development of a bnAb HIV vaccine and vaccines to other difficult pathogens, due to the significant immunological hurdles posed, including B cell immunodominance and germinal center (GC) quantity and quality. Using longitudinal lymph node fine needle aspirates, we found that two independent methods of slow delivery immunization of rhesus macaques (RM) resulted in larger GCs, more robust and sustained GC Tfh cell responses, and GC B cells with improved Env-binding, which correlated with the development of ~20 to 30-fold higher titers of tier 2 HIV-1 nAbs. Using a new RM genomic immunoglobulin loci reference sequence, we identified differential IgV gene usage between slow delivery immunized and conventional bolus immunized animals. The most immunodominant IgV gene used by conventionally immunized animals was associated with many GC B cell lineages. Ab mapping of those GC B cell specificities demonstrated targeting of an immunodominant non-neutralizing trimer base epitope, while that response was muted in slow delivery immunized animals. Thus, alternative immunization strategies appear to enhance nAb development by altering GCs and modulating immunodominance of non-neutralizing epitopes.
- Downloaded 1,255 times
- Download rankings, all-time:
- Site-wide: 18,938
- In immunology: 650
- Year to date:
- Site-wide: 128,453
- Since beginning of last month:
- Site-wide: 106,506
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!